← Back to Search

Procedure

Prospective group (>1600 grams) for Fever

N/A

Recruiting

Research Sponsored by Augusta University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Infants with a birth weight <1600 gm

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from birth date to hospital discharge, assessed up to 52 weeks

Awards & highlights

Study Summary

This trial aims to investigate if it is safe and possible to transfer babies from the incubator to a crib or bassinet at a lower weight of 1600 grams. The researchers believe that this early

Who is the study for?

This trial is for infants born weighing less than 1600 grams. It's not open to those with slow heart rates needing stimulation, babies needing strong light therapy for jaundice, those requiring significant breathing support, or infants with major birth defects.Check my eligibility

What is being tested?

The study tests the safety of moving babies from an incubator to a crib at a lower weight (1600 grams) than usual. The goal is to see if this early weaning can shorten hospital stays without affecting growth rate.See study design

What are the potential side effects?

Potential side effects may include difficulty maintaining body temperature which could lead to hypothermia or fever. Close monitoring will be required to ensure the infant's safety during the transition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My baby was born weighing less than 1600 grams.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from birth date to hospital discharge, assessed up to 52 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from birth date to hospital discharge, assessed up to 52 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and from birth date to hospital discharge, assessed up to 52 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Length of hospital stay

Secondary outcome measures

Growth velocity

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prospective group (>1600 grams)Experimental Treatment1 Intervention

The prospective group is weaned from incubator to crib at a postnatal weight of >1600 grams following consent process.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor

211 Previous Clinical Trials

85,018 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots for patients to participate in this research study?

"Indeed, according to the information available on clinicaltrials.gov, this ongoing trial is actively seeking eligible patients. The trial was initially posted on July 21st, 2023 and subsequently updated on January 19th, 2024. To meet its objectives, the study aims to enroll a total of 50 participants from a single site."

Answered by AI

What is the overall count of individuals involved in this research endeavor?

"Indeed, the information available on clinicaltrials.gov indicates that this trial is currently in search of eligible participants. The initial posting date was July 21st, 2023, and the most recent update occurred on January 19th, 2024. This study aims to enroll a total of 50 individuals at one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Early Weaning From Incubator To Crib

2023. "Early Weaning From Incubator To Crib". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06230172.

All > Columbia